Home > 暂无记录 Signal Pathway > NF-κB

NF-κB


NF-κB is important in regulating cellular responses because it belongs to the category of "rapid-acting" primary transcription factors, i.e., transcription factors that are present in cells in an inactive state and do not require new protein synthesis in order to become activated (other members of this family include transcription factors such as c-Jun, STATs, and nuclear hormone receptors). This allows NF-κB to be a first responder to harmful cellular stimuli. Known inducers of NF-κB activity are highly variable and include reactive oxygen species (ROS), tumor necrosis factor alpha (TNFα), interleukin 1-beta (IL-1β), bacterial lipopolysaccharides (LPS), isoproterenol, cocaine, and ionizing radiation.

  • Diacerein EY3012

    Diacerein, a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases.

    More

  • MLN4924 EY3016

    MLN4924是一种有效的选择性NEDD8活化酶(NEDD8-activating enzyme,NAE)抑制剂，IC50为4.7 nM。

    More

  • CREB 666-15 EY3015

    CREB 666-15是有效选择性的CREB抑制剂，IC50值为81 nM。

    More

  • Oxonic acid potassium salt EY2870

    Oxonic acid potassium salt是尿酸酶抑制剂，能抑制5-FU磷酸化为5-fluorouridine-5'-monophosphate。

    More

  • Xylometazoline HCl EY2862

    Xylometazoline is an α-adrenoceptor agonist commonly used as nasal decongestant, exhibits highest potency at α2B-adrenoceptor subtype with EC50 of 99 μM. Phase 4.

    More

  • Diacerein EY3012

    Diacerein, a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases.

    More

  • MLN4924 EY3016

    MLN4924是一种有效的选择性NEDD8活化酶(NEDD8-activating enzyme,NAE)抑制剂，IC50为4.7 nM。

    More

  • CREB 666-15 EY3015

    CREB 666-15是有效选择性的CREB抑制剂，IC50值为81 nM。

    More

  • Oxonic acid potassium salt EY2870

    Oxonic acid potassium salt是尿酸酶抑制剂，能抑制5-FU磷酸化为5-fluorouridine-5'-monophosphate。

    More

  • Xylometazoline HCl EY2862

    Xylometazoline is an α-adrenoceptor agonist commonly used as nasal decongestant, exhibits highest potency at α2B-adrenoceptor subtype with EC50 of 99 μM. Phase 4.

    More
    • Current page2, Total Pages28, Total Record140 First Prev 12345 Next Last Goto
More